Estrogen is said to stimulate cellular tissue growth especially in the estrogen sensitive female reproductive organs. The hormone progesterone makes tissue more fertile and helps to control duration and intensity of estrogenic effect. When a woman's estrogen or progesterone production and tissue effects are balanced, normal menstrual cycling continues until menopause.

An imbalance in natural hormone levels, as well as exposure to hormone-like substances (xenosteroids) from pharmaceutical drugs and environmental factors, can evoke many disturbances in the female reproductive tissues. Such imbalances may trigger abnormal tissue growth within the breast and other female reproductive areas. This activity within the uterus can lead to the development of fibrin nests and eventually the growth of fibroids.

This is why Fibroid growth is thought by experts to be closely related with estrogen dominance and is said to be a prime contributor to the deregulation of normal function experienced by not only women approaching, transitioning, and resolving the challenge of menopause, but also young women experiencing difficulty when fertility begins also referred to as menarche.

The imbalance is initially characterized by a number of factors:

-A sudden decrease in DHEA due to stress, aging, poor diet, side effects of prescription drugs etc.

-Decrease in progesterone effect due to absolute decrease in synthesis secondary to inadequate cholesterol down-conversion and increasing insensitivity of progesterone receptors.

-The activation of a cross-conversion pathway which then forces progesterone to act as a source for the synthesis of estrogens thereby decreasing both its bioavailability as a hormone, and as a substrate for the formation of adrenal cortical hormones.

Like most endocrinology this concept is difficult for the average person as well as many physicians to fully comprehend.This concept is important because, it demonstrates that the best way to address conditions such as abnormal tissue growth and inflammation, is by providing the body with natural compounds that it can use to enhance processes that it already has in place to decrease symptoms and potentially undo tissue changes.

The inclusion of a DHEA supplement may indirectly increase progesterone synthesis and act to alleviate the need for available progesterone scavenged to promote a significant source for the synthesis of estrogen; relying less on progesterone as source for estrogen conversion allowing progesterone to act freely opposing estrogen.

FibroVera is a proprietary blend of microbial and botanical components selected to address these hormonal imbalances. As mentioned earlier these imbalances such as estrogen dominance activate the secretion of excess fibrin which may lead to abnormal cell formation in the breast and uterine tissue while increasing symptoms of PMS.

FibroVera also provides fibrinolytic enzymes a fibrin eating enzymes and cofactors that are specifically selected to address excess fibrin buildup; the primary components of endometriosis or fibroids. A mildly tipping of hormonal equilibration in favor of balance can significantly reduce the speed and intensity at which fibroids can grow. This allows the fibrinolytic enzymes in FibroVera to soften, breakup and eventually dissolve abnormal tissue development without significant opposition.

FibroVera is intended to modulate hormonal response, restoring inherent processes in a woman